HeroesResearch.org clinical research registry launches to answer crucial questions about the impact of novel coronavirus on healthcare workers’ lives

EDINBURG, Texas – DHR Health Institute for Research and Development is proud to support the Healthcare Worker Exposure Response & Outcomes (HERO) Registry to join with other U.S. healthcare workers in sharing clinical and life experiences in order to understand the perspectives and problems faced by those on the COVID-19 pandemic front lines. 

The registry will unite America’s healthcare workers into a community to facilitate rapid-cycle research, including an upcoming large study of hydroxychloroquine’s effectiveness in preventing coronavirus infections in healthcare workers. The HERO research program leverages PCORnet®, the National Patient-Centered Clinical ResearchNetwork, and is funded by the Patient-Centered Outcomes Research Institute (PCORI).

The HERO Registry is asking hundreds of thousands of healthcare professionals to participate, including nurses, therapists, physicians, emergency responders, food service workers, environmental services workers, interpreters, and transporters – anyone who works in a setting where people receive health care. 

“We’re calling on healthcare workers in the Rio Grande Valley to share their perspectives so that we can understand and provide answers to the problems they face in real time – and over time,” said Manish Singh, MD, Chief Executive Officer, DHR Health. “This is the time to be proactive, to develop ways to stay safe on the front lines. I encourage everyone to be a part of HERO—and part of the solution.”

The goals of the registry are to engage healthcare workers in a research community, understand their experiences and interests through ongoing surveys, and track critical health outcomes associated with caring for patients with COVID-19, such as stress and burnout. The HERO Registry will help speed clinical studies that address unmet needs for healthcare workers.

“We have strong working partnership with PCORnet® to address major healthcare issues,” said Sohail Rao, MD, MA, DPhil, President and Chief Executive Officer, DHRHealth Institute for Research and Development. “COVID-19 is a pandemic that our community is facing today and DHR Health and the DHR Health Institute for Research and Development is working with regional partners to meet this challenge.”

There is no cost to enroll in the HERO Registry and registration takes only a few minutes. Healthcare workers can participate as much or as little as they like in surveys and other opportunities. The registry will follow a protocol developed by the Duke Clinical Research Institute and data guidelines to keep healthcare worker information secure.

To learn more about the HERO Registry, visit https://heroesresearch.org.


DHR Health Institute for Research and Development leads the way for innovative clinical research in the Rio Grande Valley.  For more information, please call (956) 362-2390 or visit our website at www.dhrresearch.org